Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 369 of 1,261
  1. US 10900973

    Therapeutic antibodies against ROR-1 protein and methods for use of same

    The Regents of the University of California · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  2. US 10900043

    Compositions and methods for treating bacterial disease

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  3. US 10900039

    Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1

    Phio Pharmaceuticals Corp. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  4. US 10899839

    Anti-Ryk antibodies and methods of using the same

    Tire Regents of the University of California · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  5. US 10899826

    Pharmaceutical compositions for an anti-CGRP antagonist antibody

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  6. US 10899879

    Biodegradable trehalose glycopolymers

    The Regents of the University of California · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  7. US 10899829

    Emapii neutralizing antibody limits influenza A virus (IAV)-induced lung injury

    United States Government as represented by the Department of Veterans Affairs · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  8. US 10899798

    Bicyclic peptide ligands with detectable moieties and uses thereof

    BicycleRD Limited · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  9. US 10899785

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    ELOXX PHARMACEUTICALS LTD. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  10. US 10899738

    Piperidines as menin inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  11. US 10899710

    Pyridines and their use in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  12. US 10899740

    Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

    The Board of Regents of the University of Texas System · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  13. US 10899732

    Substituted benzamides useful as sodium channel blockers

    Xenon Pharmaceuticals Inc. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  14. US 10898737

    Substituted piperidine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  15. US 10898583

    Harnessing quantum dots to study, visualize, and promote immune tolerance

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  16. US 10898565

    Compositions, methods and uses for dengue virus serotype-4 constructs

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  17. US 10898585

    Gene therapy for AADC deficiency

    PTC THERAPEUTICS, INC. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  18. US 10898554

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  19. US 10898575

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  20. US 10898505

    Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

    Benitec Biopharma Limited · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  21. US 10898497

    Compositions and methods for cartilage repair

    Regenexx, LLC · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  22. US 10898551

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  23. US 10898511

    Materials and methods relating to stabilised polymeric silicate compositions

    United Kingdom Research and Innovation · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  24. US 10898525

    Krill oil preparations and their uses

    AKER BIOMARINE ANTARCTIC AS · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.